BOSTON, March 12, 2024--908 Devices Inc. (Nasdaq: MASS), a pioneer of purpose-built handheld and desktop devices for chemical and biochemical analysis, announces the latest in international adoption of the MX908 for trace detection and identification of priority drugs and chemical threats. DrugDetect EU and NATO Support and Procurement Agency (NSPA) have both entered into new contracts to deploy the MX908, a handheld high-pressure mass spectrometry (HPMS) device. The MX908 will be used in a vari
908 Devices Inc. (NASDAQ:MASS) Q4 2023 Earnings Call Transcript March 5, 2024 908 Devices Inc. beats earnings expectations. Reported EPS is $-0.23, expectations were $-0.27. MASS isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, everyone, and welcome to the […]
Q4 and Full Year 2023 Earnings Highlight Handheld Device Success